🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase II trial studies how well hypofractionated radiation therapy aft...
Status
Withdrawn
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2023-10-19
Trial ID
NCT05161533
Single arm, Phase II trial of concurrent Durvalumab (MEDI 4736) and radioth...
Status
Completed
Location
Simmons Comprehensive Cancer Center at University of Texas Southwestern Medical Center - Dallas
Start Date
2020-04-03
Trial ID
NCT04003246
Treatments Being Tested
This phase I/II trials investigates the side effects of olaparib and durval...
Status
Active Not Recruiting
Location
M D Anderson Cancer Center
Start Date
2021-01-05
Trial ID
NCT04728230
Treatments Being Tested
The purpose of this clinical trial is to investigate whether the inclusion ...
Status
Not Yet Recruiting
Location
Zhongshan Hospital
Start Date
2024-07
Trial ID
NCT06502080
The purpose of this study is to evaluate the efficacy of radiotherapy as pa...
Status
Recruiting
Location
Center of Oncology of the Lublin Region St. Jana z Dukli in Lublin
Start Date
2024-04-01
Trial ID
NCT06529081
Treatments Being Tested
This study is designed to determine if combining consolidative radiation th...
Status
Terminated
Location
University of Nebraska Medical Center
Start Date
2021-07-15
Trial ID
NCT04748419
Treatments Being Tested
Open-label, single-arm, prospective multicenter phase II clinical trial to ...
Status
Recruiting
Location
University Hospital Augsburg, Radiation Oncology
Start Date
2023-10-06
Trial ID
NCT06223711
This phase III trial studies how well an antibody (durvalumab) with chemoth...
Status
Active Not Recruiting
Location
Anchorage Associates in Radiation Medicine
Start Date
2020-04-29
Trial ID
NCT04092283
Treatments Being Tested
This phase II trial finds out the effect of local consolidative therapy and...
Status
Recruiting
Location
M D Anderson Cancer Center
Start Date
2021-07-07
Trial ID
NCT04892953